✦ LIBER ✦

Acute tumor lysis syndrome after rituximab administration in Burkitt’s lymphoma

✍ Scribed by Zaher K. Otrock; Hassan A. Hatoum; Ziad M. Salem

Book ID: 107481092
Publisher: Springer Milan
Year: 2008
Tongue: English
Weight: 159 KB
Volume: 3
Category: Article
ISSN: 1828-0447
DOI: 10.1007/s11739-008-0099-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute tumor lysis syndrome: A review of

Acute tumor lysis syndrome: A review of 37 patients with Burkitt's lymphoma

✍ Lawrence F. Cohen; James E. Balow; Ian T. Magrath; David G. Poplack; John L. Zie 📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 772 KB

Acute tumor lysis syndrome after intrath

Acute tumor lysis syndrome after intrathecal methotrexate administration

✍ Elizabeth D. Simmons; Kenneth A. Somberg 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB

Acute Tumor Lysis Syndrome Induced by Ri

Acute Tumor Lysis Syndrome Induced by Rituximab in Diffuse Large B-Cell Lymphoma

✍ Fadi I. Jabr 📂 Article 📅 2005 🏛 Carden Jennings Publishing 🌐 English ⚖ 58 KB

Tumor Lysis Syndrome Occurring After the

Tumor Lysis Syndrome Occurring After the Administration of Rituximab for Posttransplant Lymphoproliferative Disorder

✍ S.A. Francescone; B. Murphy; J.T. Fallon; K. Hammond; S. Pinney 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 990 KB

A case report of fatal tumor lysis syndr

A case report of fatal tumor lysis syndrome after chemotherapy in a pregnant patient with Burkitt's lymphoma

✍ Takehiro Serikawa; Takashi Abe; Takahiro Minamikawa; Mina Itsukaichi; Kyoko Yama 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB

Tumor lysis syndrome occurring after the

Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: High-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia

✍ Yang, Honghao; Rosove, Michael H.; Figlin, Robert A. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 27 KB 👁 2 views

Rituximab, an anti-CD20 antibody, has been recently approved for the treatment of lowgrade or follicular non-Hodgkin's lymphoma (NHL). Because of its relatively benign side effect profile, it has been considered a nontoxic alternative to chemotherapy. Recently, however, tumor lysis syndrome (TLS) re